Transcode Therapeutics : Has Regained Compliance With Minimum Bid Price Requirement Set Forth in Nasdaq Listing Rule 5550(a)(2)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.